Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Analgesia in Head and Neck Cancer Surgery
NCT03682367Phase 3Terminated
- Sponsor
- University of California, Davis
- Start
- Dec 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gabapentin in postoperative pain, sponsored by University of California, Davis. Started Dec 2018; status: terminated.
02
Drugs
gabapentin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03682367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03682367.